Usana Health Sciences Inc (USNA) — Titan Protect Analysis

USNA

Usana Health Sciences Inc

Consumer Defensive · ·

$18.03

Data: 2026-06-03

✓ ETHICAL PASS

NONE MOAT

LIMITED

Data Confidence: 0.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$326M

Total market value of the company

Trailing P/E

35.36

Expensive — high growth expected

Forward P/E

6.38

Based on estimated future earnings — lower means cheaper

Rev Growth

+0.3%

Year-over-year revenue change

Profit Margin

1.0%

How much profit the company keeps from each dollar of revenue

ROE

1.6%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$39.00

+116% from current price — median analyst estimate

Recommendation

NONE

Consensus view from 1 analysts covering this stock

About Usana Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 1

https://www.usana.com

Country: United States Employees: 1,570 Industry: Packaged Foods

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% PENDING

Debt must be below 33% of total assets

Cash Ratio

0.0% PENDING

Interest-bearing cash below 33% of assets

Receivables

0.0% PENDING

Receivables below 49% of assets

Revenue Purity

0.0% PENDING

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

DISTRIBUTION

Smart money appears to be selling into strength — caution

Sharpe Ratio

-0.930

Returns do not compensate for the risk — negative edge

Kelly Fraction

-0.1001

No positive edge detected — the data suggests staying out

Calmar Ratio

-0.600

Drawdown risk outweighs the returns — higher risk profile

Annual Return

-39.3%

Historical annualised return based on price data

Max Drawdown

-65.4%

Largest peak-to-trough decline — the worst it has been

HMM State

SIDEWAYS

Price consolidating — no clear directional bias

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

0.77

Less volatile than the market — more defensive

52W High

$38.32

53% below the year high

52W Low

$16.60

9% above the year low

Avg Volume

125,820

Average daily shares traded — higher means easier to buy and sell

Short Ratio

5.4

Days it would take all short sellers to cover — higher means more crowded

Short % Float

N/A

Div Yield

N/A

Annual dividend as a percentage of the share price

EPS (TTM)

$0.50

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

2.35

Heavy leverage — higher financial risk if revenues decline

Current Ratio

N/A

Quick Ratio

N/A

Like current ratio but excludes inventory — stricter test

Gross Margin

77.6%

Revenue left after cost of goods — higher means pricing power

Operating Margin

5.5%

Profit from core operations before interest and tax

Free Cash Flow

$30M

Positive — the business generates more cash than it spends

Revenue (TTM)

$926M

Total revenue over the last 12 months

Net Income

$9M

Profitable — the bottom line is positive

Analyst Coverage

Analysts

Target High

$39.00

Target Median

$39.00

Target Low

$39.00

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-06-03

Before you go